About: Long-term efficacy of reduced-intensity versus myeloablative conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: retrospective follow-up of an open-label, randomised

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Long-term efficacy of reduced-intensity versus myeloablative conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: retrospective follow-up of an open-label, randomised Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 14 March 2018

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) scientific article published on 14 March 2018 (en) գիտական հոդված հրատարակված 2018 թվականի մարտի 14-ին (hy) im März 2018 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en marzu de 2018 (ast) наукова стаття, опублікована 14 березня 2018 (uk)
publication date	wds:Q88088400-E1499087-05E8-4FB9-8588-F78F98F3B5F3
publication date	2018-03-14 00:00:00Z (xsd:dateTime)
cites work	wds:Q88088400-0EF0DFE8-AC42-4E63-B747-E85B9784A167 wds:Q88088400-105F5D5F-A324-471C-99F9-DB0B7DDC2E3F wds:Q88088400-14698B1B-E5AD-4A0B-9B6C-62CD46D135D5 wds:Q88088400-1BC49624-9820-4964-8879-5B9851977748 wds:Q88088400-2749C294-9732-48A2-9E21-3D970B0D5691 wds:Q88088400-3C9B59E2-9F87-4D78-869A-E292E46A3635 wds:Q88088400-4152077E-991C-45E0-8866-7DAA1BDB4330 wds:Q88088400-49C6788E-D8C7-4CED-86D2-7E9302BFBE19 wds:Q88088400-562D0755-3A62-4AD5-8F5C-189FDD8F3754 wds:Q88088400-572B800B-6383-4F98-8496-D7FBC544CBDE wds:Q88088400-5C81E4B1-7822-4C7A-8D0E-80D6FAC6149E wds:Q88088400-5D0D68E5-4811-40B8-8181-D23856372CB8 wds:Q88088400-696E592D-4412-4236-BC4D-13AEEBF9157D wds:Q88088400-86272E65-59E1-4A89-A8E1-4C486F68D0ED wds:Q88088400-9B106C5A-0CB8-46D1-8B8A-860F4446D126 wds:Q88088400-9DEAE462-3C77-4AC8-BEAE-8CEADBF7333C wds:Q88088400-A1F1341C-F6D5-4ADD-9D1D-646927430E8C wds:Q88088400-AEBE1523-9DB0-40C6-9D22-2562AAB13FAA wds:Q88088400-B1D2C48A-A799-46CA-87FD-D2E838D15423 wds:Q88088400-C01A7F65-98E8-4BE3-A988-3456CA404458 wds:Q88088400-C4E904CD-325F-4912-BEFD-E94A8499FEAF wds:Q88088400-D4A16A7E-B166-433F-A514-28942577ED9B wds:Q88088400-E4050ED8-5B6E-42BA-A54D-69DDFC23429D wds:Q88088400-E46F0CD9-BBB4-496B-96FD-A88799F98D73 wds:Q88088400-E70DFB45-6FA8-45E8-B33D-65CFA354E17E wds:Q88088400-FACACF83-4C70-4F3B-B7F1-26AD1A1ABB31
cites work	Comparable outcomes after nonmyeloablative hematopoietic cell transplantation with unrelated and related donors Marrow transplantation for acute nonlymphoblastic leukemic in first remission using fractionated or single-dose irradiation Allogeneic transplantation versus chemotherapy as postremission therapy for acute myeloid leukemia: a prospective matched pairs analysis Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial. Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies Defining the intensity of conditioning regimens: working definitions Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation Conditioning with 8-Gy total body irradiation and fludarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia Solid cancers after allogeneic hematopoietic cell transplantation Long-term survival and late deaths after allogeneic hematopoietic cell transplantation Long-term survival and late events after allogeneic stem cell transplantation from HLA-matched siblings for acute myeloid leukemia with myeloablative compared to reduced-intensity conditioning: a report on behalf of the acute leukemia working party o Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel Graft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantation Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry Quantification of the completeness of follow-up. Secondary malignancies after allogeneic stem-cell transplantation in the era of reduced-intensity conditioning; the incidence is not reduced Comparison of reduced-intensity and myeloablative conditioning regimens for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia and acute lymphoblastic leukemia: a meta-analysis National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report Randomized trial of myeloablative conditioning regimens: busulfan plus cyclophosphamide versus busulfan plus fludarabine. Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes Randomized study of 2 reduced-intensity conditioning strategies for human leukocyte antigen-matched, related allogeneic peripheral blood stem cell transplantation: prospective clinical and socioeconomic evaluation Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial. Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial). Conditioning intensity in middle-aged patients with AML in first CR: no advantage for myeloablative regimens irrespective of the risk group-an observational analysis by the Acute Leukemia Working Party of the EBMT.
author name string	wds:Q88088400-15074E94-77C7-4F01-B48E-5B0BB9AEACA7 wds:Q88088400-5DA67FB9-F881-49D5-9C47-5BEEC595F865 wds:Q88088400-7811A21B-C719-4E4F-9456-F786DDD82C43 wds:Q88088400-8C6F5EA3-E17B-4E33-AFDE-19D112AA4317 wds:Q88088400-9A8B6C9B-43D6-482A-9C48-4CA3CCA3822A wds:Q88088400-9B6E020A-2579-4785-BD9B-CC33E960608F wds:Q88088400-BD9A9062-125F-4EEB-9E5E-9D8147B815BE wds:Q88088400-D9B78970-62C9-4B82-9053-473488076ED9
author name string	Andreas Neubauer Michael Kramer Wolfgang E Berdel Timo Siepmann Martin Stuschke Michael Stadler Hans Eich Michael Bätzel
rdfs:label	Long-term efficacy of reduced-intensity versus myeloablative conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: retrospective follow-up of an open-label, randomised (en) Long-term efficacy of reduced-intensity versus myeloablative conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: retrospective follow-up of an open-label, randomised (nl)
skos:prefLabel	Long-term efficacy of reduced-intensity versus myeloablative conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: retrospective follow-up of an open-label, randomised (en) Long-term efficacy of reduced-intensity versus myeloablative conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: retrospective follow-up of an open-label, randomised (nl)
name	Long-term efficacy of reduced-intensity versus myeloablative conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: retrospective follow-up of an open-label, randomised (en) Long-term efficacy of reduced-intensity versus myeloablative conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: retrospective follow-up of an open-label, randomised (nl)
author	wds:Q88088400-04FED406-AA18-47A2-8FF3-3DDBA44CD2AD wds:Q88088400-09243924-17F7-49E2-9FA9-CD50E723A5AC wds:Q88088400-15250797-6FA0-4B6F-BE45-38B2D90DFD36 wds:Q88088400-2A3C8D86-DA3C-4568-B0A3-2CF9DF87C98A wds:Q88088400-346047E5-6E64-45C9-B0A7-9887BEB4841A wds:Q88088400-4170B85E-CB38-4EC0-A6A5-01BA540F21A3 wds:Q88088400-5F471412-793B-41A9-B2C2-5FF437EFCB23 wds:Q88088400-68DD07D5-94C9-4208-99E6-7FD6A0237F0D wds:Q88088400-79F223D8-0CF1-4354-B5E5-69447A742653 wds:Q88088400-8F12004E-5D5C-49E9-96C9-0FD0C4D2C92F wds:Q88088400-B7679F94-2907-41A5-AC9F-A6B7D14B5764 wds:Q88088400-D6FA22CF-EC9B-4D89-AF88-60354D33D7A0 wds:Q88088400-DAF095C6-04AF-4CB8-9505-046AA994FC5C
author	Gerhard Ehninger Kerstin Schäfer-Eckart Martin Bornhäuser Johannes Schetelig

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software